BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Deals

  Teva Pharmaceutical Industries Limited Buys Rest of Japanese JV for $150 Million

  September 26, 2011

   · 

  1 min read
• Drug Development

  Positive Phase III Data on Bayer HealthCare Pharmaceuticals Investigational Drug Radium-223 Chloride Show Significant Increase in Overall Survival

  September 26, 2011

   · 

  5 min read
• Zhongsheng Pharma Commits $3 Million to Three Novel Drugs

  September 26, 2011

   · 

  1 min read
• Business

  RXi Pharmaceuticals Plans to Split into Two Public Firms

  September 26, 2011

   · 

  1 min read
• Drug Development

  Novartis AG’s Afinitor Shows Promise in Breast Cancer

  September 26, 2011

   · 

  13 min read
• Drug Development

  Bone-Strengthening Drug Gives Pain Relief in Prostate Cancer Bone Metastases, Mount Vernon Cancer Centre Study

  September 26, 2011

   · 

  1 min read
• Business

  PharmAthene, Inc. Appoints Brian A. Markison to the Company’s Board of Directors

  September 26, 2011

   · 

  4 min read
• Drug Development

  Eli Lilly and Company’s ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for Deadly Form of Lung Cancer

  September 26, 2011

   · 

  8 min read
• Drug Development

  Ampio Pharmaceuticals, Inc. Announces Positive Results From 12-Week Open Label Extension Study of Zertane in Patients With Premature Ejaculation

  September 26, 2011

   · 

  3 min read
• Drug Development

  Action Pharma’s Phase 2b Clinical Trial with AP214 to Prevent Kidney Injury Associated with Major Cardiac Surgery Demonstrates Positive Top-Line Results

  September 26, 2011

   · 

  4 min read